Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination.
Annual outbreaks of seasonal influenza are controlled or prevented through vaccination in many countries. The seasonal vaccines used are either inactivated, currently administered parenterally, or live-attenuated given intranasally. In this study three mucosal adjuvants were examined for the influen...
Main Authors: | Tina Falkeborn, Andreas Bråve, Marie Larsson, Britt Akerlind, Ulf Schröder, Jorma Hinkula |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3738562?pdf=render |
Similar Items
-
Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
by: Jorma Hinkula, et al.
Published: (2019-07-01) -
Nasal vaccination using novel mucosal adjuvants : with main focus on influenza A virus
by: Falkeborn, Tina
Published: (2015) -
DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
by: Steven E. Applequist, et al.
Published: (2013-09-01) -
Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice.
by: Yoshiko Fukuyama, et al.
Published: (2015-01-01) -
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
by: Yujie Zhang, et al.
Published: (2020-06-01)